1. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms;Tefferi;Leukemia,2008
2. The incidence and outcome of myeloid malignancies in 2112 adult patients in South East England;Phekoo;Haematologica,2006
3. Incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the Côte d'Or area, France, during 1980-99;Girodon;J. Intern. Med.,2005
4. Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Goteborg, Sweden, during 1983-99;Johansson;J. Intern. Med.,2004
5. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24, 577 first-degree relatives of 11, 039 patients with myeloproliferative neoplasms in Sweden;Landgren;Blood,2008